SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers recovery to a one-year high and push through a long-watched resistance area are driving attention, with long-term holders celebrating the turnaround and traders watching for a sustained breakout. Others remain cautious, citing resistance and the lack of a clear new catalyst to support further gains.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus stock-and-warrant offering has intensified concern about shareholder dilution and contributed to a steep selloff, alongside broader weakness in nuclear stocks. Traders are divided between viewing the pullback as a buying opportunity tied to domestic uranium-enrichment demand and worrying that valuation, expansion costs, and execution risks outweigh the long-term HALEU and DOE-contract potential.

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

Discussion is focused on the $17.05 million investor settlement: eligible shareholders are being reminded to file claims before the deadline, with a final approval hearing scheduled immediately afterward. Some traders view clearing the legal overhang as a positive, while others emphasize the settlements limited per-share recovery and historical allegations about Twists production and financial disclosures.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635, AbCelleras investigational treatment for menopausal hot flashes: traders are reacting to encouraging Phase 2 results and a conference presentation, while watching for further data on durability, safety and patient-reported outcomes. Sentiment is broadly bullish, though some investors question whether the presentation adds much beyond the reported results and caution that the stocks sharp moves may be volatile.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Anticipation of Lillys quarterly results is driving discussion, with traders looking for continued Mounjaro and Zepbound growth and a possible guidance lift. Optimism about Lillys GLP-1 leadership is tempered by debate over Foundayos traction against Novos oral pill, emerging competitors, and whether recent gains have already priced in strong results.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Phase 3 lung-cancer results for IMDELLTRA plus Imfinzi are drawing attention, with traders focused on the reported survival benefit and potential to expand the drugs role in earlier treatment. The community views the data as a meaningful pipeline catalyst, though some question how much it will change Amgens broader growth outlook.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Traders are focused on Zebecs payroll and payments adoption story, including reported Stellar/MoneyGram and European developments, alongside Robinhood-related integration chatter that some users treat as unconfirmed. Bulls see partnerships, usage growth and buybacks as potential sources of token demand, while skeptics argue that adoption has yet to translate into stronger price performance.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons move to record highs is drawing attention as traders weigh elevated crude prices and unusually strong refining margins ahead of its quarterly report. Some expect those tailwinds to support results, while others question whether refining gains will last and note the higher bar set by raised earnings expectations.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies expanded share-repurchase program is drawing attention, with traders seeing potential support for PURR while others question whether it can offset concerns about share issuance and weakness in HYPE, the token held in the companys treasury. The discussion also reflects mixed views on how closely PURR should track HYPE.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

Traders are focused on SQQQ as a leveraged bet or hedge against further Nasdaq weakness, citing tech selling and concerns that heavy AI spending may not generate adequate returns. Some expect the pullback to deepen, while others warn that SQQQs daily-reset structure makes it risky to hold through volatile or rising markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AAPL Man loses most of $2.5 million in market; bets remaining $300,000 that Apple will have a big earnings miss https://www.reddit.com/r/wallstreetbets/comments/5qhzcy/well_this_is_it_going_allin_my_last_stand_my/

Faiz

Kevin

Brian

Frank R www.clueless8.com

LoganFive

Stocktwits

Tony

Stock Market Cinema

Frankie Weaselsmith

cringecaverns

Deek It's Deek man

Shinji

Leo Wai

MikeyVegas

jaychua

Reddit

reddit.com: over 18?

Michael Angel

$AAPL cringeworthy article, yet I sympathize also as the many  Learning Lessons are crystal clear to me. #eeks

StockTwits for iOS

ModifiedDarvasBox

$AAPL The final YOLO. Wow people. Learn from this.

Apple Inc

 Man loses most of $2.5 million in market; bets remaining $300,000 that Apple will have a big earnings miss 

David Moadel

Slim Trady

@The_Real_Slim_Trady F. S. Comeau. Interesting guy, to say the least.  No clue if his story is real or fake, but it&#39;s definitely interesting

 F. S. Comeau. Interesting guy, to say the least.  No clue if his story is real or fake, but it's definitely interesting

@davidmoadel Yeah, seems like he put lots of thought into it......his scenarios on Apple are mostly insane!!!

 Yeah, seems like he put lots of thought into it......his scenarios on Apple are mostly insane!!!

@davidmoadel @fscomeau I don&#39;t even know where the trolling begins/ends anymore. #WSB

 I don't even know where the trolling begins/ends anymore. 

JoeProtist

@JoeProtist @fscomeau Always assume trolling until you have a compelling reason not to...

 Always assume trolling until you have a compelling reason not to...

@JoeProtist @fscomeau LOL yep, he&#39;s supposedly giving away Canadian maple syrup to a bunch of Reddit posters if he wins $1 million on $AAPL

 LOL yep, he's supposedly giving away Canadian maple syrup to a bunch of Reddit posters if he wins $1 million on 

@davidmoadel @JoeProtist @fscomeau he should be paying off debt first.

StockTwits For Android 

Trade Cruz

@tradecruz @JoeProtist @fscomeau I agree with you on that. He says he&#39;s got nothing left to lose, but $300,000 Canadian is a lot of money

 I agree with you on that. He says he's got nothing left to lose, but $300,000 Canadian is a lot of money

@davidmoadel stunning, not just the losses but all the rest, almost every bad choice one could make in the book was taken beforehand

 stunning, not just the losses but all the rest, almost every bad choice one could make in the book was taken beforehand

Edward Rooster

@davidmoadel  @JoeProtist @fscomeau feel sorry for his uncle.

@edwardrooster Well said. Entertaining to witness though.....

 Well said. Entertaining to witness though.....

@davidmoadel Fortunately for our pseudonymous friend &quot;F.S.&quot; his short bet on $AAPL might just pay off this week.

 Fortunately for our pseudonymous friend "F.S." his short bet on 

Gabriel

@Dollarz Sure it could.... but even if it pays him handsomely, that doesn&#39;t mean it was a good idea $AAPL

 Sure it could.... but even if it pays him handsomely, that doesn't mean it was a good idea 

@davidmoadel Imagine the risk free return he could have had if he just invested it in t-bills and allowed the interest to compound. Oh man.

 Imagine the risk free return he could have had if he just invested it in t-bills and allowed the interest to compound. Oh man.

Nick With-Seidelin

@nickinator93 Yep. It&#39;s a shame but I enjoy a self-destructive Shakespearean tragedy

 Yep. It's a shame but I enjoy a self-destructive Shakespearean tragedy

@davidmoadel It sounds like this guy should stay away from the stock market.

 It sounds like this guy should stay away from the stock market.

Tony Muse

@TheMuser For his sake, yes. For the same of our entertainment, heck no, I wanna see him gamble!

 For his sake, yes. For the same of our entertainment, heck no, I wanna see him gamble!

@davidmoadel don&#39;t bet against Apple $APPL. A loosing bet.

 don't bet against Apple $APPL. A loosing bet.

scott sauer

@davidmoadel  You&#39;re a cruel, cruel man.  LOL

georges mikes

@laylash Quite possibly a hoax, but a heck of an entertaining one.

 Quite possibly a hoax, but a heck of an entertaining one.

@davidmoadel Martin Shkreli says FS Comeau&#39;s crazy &amp; should stop trading $AAPL yesterday. https://www.facebook.com/martinshkr/videos/vb.16400586/10101376433632925/?type=2&amp;theater&amp;notif_t=live_video&amp;notif_id=1485819759379307

Facebook

Martin Shkreli - Crazy $AAPL guy | Facebook

 Martin Shkreli says FS Comeau's crazy & should stop trading 

Dave Nathanson

@DrDave LOL everybody&#39;s ripping Comeau! I&#39;ll bet he likes the attention though $AAPL

 LOL everybody's ripping Comeau! I'll bet he likes the attention though 

@next2nothing You kidding? Best part of the video! $AAPL

@next2nothing Depressing for all of us, believe me.

@davidmoadel Trump totally screwed me over,when I heard that he was meeting with CEOs of Drug companies,I thought he was going to mess it up

 Trump totally screwed me over,when I heard that he was meeting with CEOs of Drug companies,I thought he was going to mess it up